Clinical Trial Detail

NCT ID NCT02967133
Title A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications

lung non-small cell carcinoma

Therapies

Nab-paclitaxel + Nivolumab

Nivolumab

Age Groups: adult senior

No variant requirements are available.